Home

Case Study

AI-ENHANCED MOLECULAR MODELING SHORTENS THE PATH TO MARKET OF NEW DRUGS

AI-ENHANCED MOLECULAR MODELING SHORTENS THE PATH TO MARKET OF NEW DRUGS

Viridien Group
Pages 1 Pages

Viakoo helped biosimulytics by providing a secure and compliant IoT environment that supports their advanced AI and high-performance computing platform for drug development. Through continuous monitoring, automated vulnerability detection, and remediation, Viakoo ensured biosimulytics could focus on accelerating drug molecule simulations without security risks or operational disruption. This partnership enabled faster, cost-effective, and reliable drug development processes by maintaining robust security and operational integrity across their cloud and IoT infrastructure.

Join for free to read

You Might Also Like


The Path to Acceleration: In Silico Modeling Launches New Wave of Rare Disease Drug Development
White Paper The Path to Acceleration: In Silico Modeling Launches New Wave…
Premier Research

Accelerating Molecular Modeling with oneAPI and Intel® FPGA Accelerators
Case Study Accelerating Molecular Modeling with oneAPI and Intel® FPGA…
Intel

The Ultimate Guide to Generative AI Enhanced Decisions
Ebook The Ultimate Guide to Generative AI Enhanced Decisions
Evalueserve

Boost Efficiencies and Get Drugs to Market Faster
Ebook Boost Efficiencies and Get Drugs to Market Faster
DocuSign
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info